EC Number | Cloned (Comment) | Organism |
---|---|---|
5.4.99.24 | - |
Escherichia coli |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.2.12 | additional information | lack of pseudouridine at position 2504 of 23S rRNA significantly increases the susceptibility of Escherichia coli to peptidyl transferase inhibitors | Escherichia coli |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.2.12 | Escherichia coli | - |
- |
- |
5.4.99.24 | Escherichia coli | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.99.24 | 23S rRNA uridine955/uridine2504/uridine2580 | - |
Escherichia coli | 23S rRNA pseudouridine955/pseudouridine2504/pseudouridine2580 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.4.99.24 | RLuc | - |
Escherichia coli |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.2.12 | physiological function | some of the indigenous posttranscriptional modifications of rRNA can be viewed as intrinsic antibiotic resistance mechanisms. The lack of pseudouridine at position 2504 of 23S rRNA significantly increases the susceptibility of Escherichia coli to peptidyl transferase inhibitors | Escherichia coli |
5.4.99.24 | malfunction | in the rluC- strain, susceptibility to some antibiotics increases dramatically. The most pronounced effects in comparison with the rluC+ control are observed with clindamycin (16-fold), linezolid (8-fold), and tiamulin (4-fold) | Escherichia coli |